Delivery Order SPE2DB22D3301-SPE2DB25FX7WF

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,887.36 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 21, 2024. The contract has a firm fixed price and will run through September 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has a firm fixed price of $39,098.88 and a completion date of January 24, 2024. It is a delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET in quantities of 120 per shipment. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a ceiling value of $118,261.86 and an ultimate completion date of October 9, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.62 firm fixed-price delivery order covers the procurement of 4567090102 ! LYNPARZA 100 MG TABLET UU 120S, with a period of performance through February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order for LYNPARZA 150 MG TABLET UU 120S, valued at $42,270.40, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans'...
This federal contract award is a delivery order valued at $21,039.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 100 MG TABLET, a pharmaceutical product. The award has an ultimate completion date of February 27, 2025 and utilizes a firm fixed price pricing type. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,271.84 firm-fixed-price delivery order contract is for the supply of the drug Lynparza 100 mg tablets. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,774.74 for the supply of LYNPARZA 150 MG TABLET. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 9, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,179.51 firm fixed-price delivery order is for the drug LYNPARZA 100 mg tablets. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $116,179.72, was issued by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, with a period of performance through March 11, 2025. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7WF
    Delivery Order

This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,135.20 fixed-price contract with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has a period of performance through January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for comprehensive pharmaceutical and medical supply support to military healthcare programs. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 4/6/25, 12:49 AM